Avapritinib: A Selective Inhibitor of KIT and PDGFRα that Reverses ABCB1 and ABCG2-Mediated Multidrug Resistance in Cancer Cell Lines

Documenti analoghi

• The Selective Class IIa Histone Deacetylase Inhibitor TMP195 Resensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs
  di: Wu, Chung-Pu, et al.
  Pubblicazione: (2019)
• SIS3, a specific inhibitor of Smad3 reverses ABCB1- and ABCG2-mediated multidrug resistance in cancer cell lines
  di: Wu, Chung-Pu, et al.
  Pubblicazione: (2018)
• The positive inotropic agent DPI-201106 selectively reverses ABCB1-mediated multidrug resistance in cancer cell lines
  di: Hsiao, Sung-Han, et al.
  Pubblicazione: (2018)
• Tyrphostin RG14620 selectively reverses ABCG2-mediated multidrug resistance in cancer cell lines
  di: Wu, Chung-Pu, et al.
  Pubblicazione: (2017)
• Overexpression of ABCB1 and ABCG2 contributes to reduced efficacy of the PI3K/mTOR inhibitor samotolisib (LY3023414) in cancer cell lines
  di: Wu, Chung-Pu, et al.
  Pubblicazione: (2020)